Showing 1 of 1 PublicationsLarotrectinib in NTRK-Rearranged Solid TumorsWilson FH, Herbst RS. Larotrectinib in NTRK-Rearranged Solid Tumors. Biochemistry 2019, 58: 1555-1557. PMID: 30865435, PMCID: PMC7356829, DOI: 10.1021/acs.biochem.9b00126.Peer-Reviewed Original ResearchCitationsAltmetricMeSH KeywordsAntineoplastic AgentsHumansMutationNeoplasmsOncogene Proteins, FusionProtein Kinase InhibitorsPyrazolesPyrimidinesReceptor, trkAReceptor, trkBReceptor, trkCDownload Full List
Larotrectinib in NTRK-Rearranged Solid TumorsWilson FH, Herbst RS. Larotrectinib in NTRK-Rearranged Solid Tumors. Biochemistry 2019, 58: 1555-1557. PMID: 30865435, PMCID: PMC7356829, DOI: 10.1021/acs.biochem.9b00126.Peer-Reviewed Original ResearchCitationsAltmetricMeSH KeywordsAntineoplastic AgentsHumansMutationNeoplasmsOncogene Proteins, FusionProtein Kinase InhibitorsPyrazolesPyrimidinesReceptor, trkAReceptor, trkBReceptor, trkC